Empagliflozin

Generic Name: Empagliflozin

Brand Names: Jardiance

Empagliflozin is used to treat type 2 diabetes and heart failure. It is available as Jardiance and is commonly prescribed in the diabetes category.

DiabetesSGLT2 InhibitorsCardiovascular

Drug Class

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Pregnancy

Not recommended in pregnancy — Animal studies show adverse renal effects in offspring exposed during the second and third trimesters, mirroring concerns with other agents that affect renal hemodynamics. Limited human data. Discontinue empagliflozin when pregnancy is recognized and transition to insulin or other pregnancy-compatible therapy.

Available Forms

Oral tablet (10 mg, 25 mg), Fixed-dose combination with metformin (5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, 12.5 mg/1000 mg), Fixed-dose combination with linagliptin (10 mg/5 mg, 25 mg/5 mg)

What It's Used For

is prescribed to treat:

• Type 2 diabetes and heart failure • Various related conditions in the diabetes category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

Condition	Starting Dose	Maintenance Dose
Type 2 diabetes (adults)	10 mg once daily in the morning	May increase to 25 mg once daily based on tolerability and glycemic response
Heart failure (with or without diabetes, HFrEF or HFpEF)	10 mg once daily	10 mg once daily; titration to 25 mg not shown to add cardiovascular benefit
Chronic kidney disease (with or without diabetes)	10 mg once daily	10 mg once daily; do not initiate if eGFR < 20 mL/min/1.73 m²
Renal dose adjustment	Avoid initiation if eGFR < 20 mL/min/1.73 m²	Continue therapy until dialysis is required

Side Effects

Common side effects may include:

• Nausea or stomach upset • Headache • Dizziness or lightheadedness • Fatigue or tiredness • Mild rash or itching

Serious side effects (seek immediate medical attention):

• Severe allergic reactions (rash, hives, swelling, difficulty breathing) • Unusual bleeding or bruising • Severe stomach pain • Signs of liver problems (yellowing of skin/eyes, dark urine) • Chest pain or irregular heartbeat • Severe dizziness or fainting • Signs of serious adverse effects

Drug Interactions

Empagliflozin is minimally metabolized and primarily excreted unchanged. Its interactions are largely pharmacodynamic — driven by glucosuria, mild diuresis, and effects on renal hemodynamics.

Insulin and insulin secretagogues (e.g., glipizide, glimepiride, glyburide): Empagliflozin does not directly cause hypoglycemia, but combined use significantly increases hypoglycemia risk. Reduce the dose of insulin or sulfonylurea when adding empagliflozin.
Loop and thiazide diuretics (e.g., furosemide, hydrochlorothiazide): Additive volume depletion can cause hypotension, dizziness, and acute kidney injury, particularly in elderly patients. Reassess diuretic dosing when starting empagliflozin and counsel on adequate hydration.
ACE inhibitors and ARBs (e.g., lisinopril, losartan): Combination therapy is often clinically appropriate (and beneficial in heart failure and CKD), but increases risk of hyperkalemia and acute kidney injury during illness or volume depletion. Monitor renal function and electrolytes within 1–2 weeks of initiation.
Lithium: Empagliflozin may decrease lithium levels through increased urinary excretion. Monitor lithium levels when starting or stopping empagliflozin.
Strong UGT2B7 inducers (e.g., rifampin): May modestly reduce empagliflozin exposure. Monitor glycemic response if co-administered.

Additional Information

What is ?

Empagliflozin (generic name: Empagliflozin) is a medication primarily used to treat type 2 diabetes and heart failure. It is marketed under the brand name(s) Jardiance and belongs to the Diabetes category of medications.

How Does Empagliflozin Work?

Empagliflozin works through several mechanisms to provide therapeutic benefits:

Acts on specific receptors or pathways in the body
Modulates biological processes related to the treated condition
Provides symptom relief and improves quality of life
Helps manage the underlying condition effectively
Works best when combined with appropriate lifestyle modifications

The medication is designed to target the specific pathways involved in type 2 diabetes and heart failure, making it an effective treatment option.

Common Uses

Primary Indications

Empagliflozin is commonly prescribed for:

Type 2 diabetes and heart failure: The main indication for this medication
Related Conditions: Associated symptoms and complications
Prevention: May help prevent progression of certain conditions
Symptom Management: Reduces discomfort and improves daily function

Additional Uses

In some cases, Empagliflozin may also be prescribed for:

Off-label uses as determined by your healthcare provider
Combination therapy with other medications
Long-term management of chronic conditions
Short-term treatment of acute symptoms

Dosage and Administration

Empagliflozin dosing varies based on the specific condition being treated and individual patient factors.

Typical Dosing:

Starting dose is typically determined by your healthcare provider
May be adjusted based on response and tolerability
Can be taken with or without food (follow specific instructions)
Usually taken once or twice daily

Administration Tips:

Take at the same time(s) each day for best results
Swallow tablets/capsules whole unless instructed otherwise
Don't skip doses
Complete full course of treatment as prescribed
Follow your doctor's specific instructions carefully

Important Safety Information

Who Should Not Take Empagliflozin?

Do not take Empagliflozin if you:

Are allergic to Empagliflozin or any ingredients
Have certain medical conditions (discuss with your doctor)
Are taking medications that interact with Empagliflozin
Have severe liver or kidney disease (without dose adjustment)

Drug Interactions

Inform your doctor about all medications you take, including:

Prescription medications
Over-the-counter drugs
Vitamins and supplements
Herbal products

Some medications may interact with Empagliflozin, affecting its efficacy or increasing side effect risk.

Pregnancy and Breastfeeding

Pregnancy:

Discuss risks and benefits with your doctor if pregnant or planning pregnancy
May require special monitoring or dose adjustments
Some medications should be avoided during pregnancy

Breastfeeding:

Consult your doctor about safety while breastfeeding
May pass into breast milk
Benefits and risks should be carefully considered

Monitoring and Follow-Up

While taking Empagliflozin, your doctor may monitor:

Effectiveness of treatment (symptom improvement)
Side effects or adverse reactions
Laboratory values if applicable
Blood pressure, heart rate, or other vital signs as appropriate
Overall response to therapy

Regular follow-up appointments are important to ensure the medication is working properly and to make any necessary adjustments.

Managing Side Effects

Most side effects are mild and improve with time. Here are strategies for common side effects:

Gastrointestinal Upset

Take with food if allowed
Stay well hydrated
Eat smaller, more frequent meals
Report persistent nausea or vomiting

Dizziness

Rise slowly from sitting or lying positions
Avoid sudden movements
Stay hydrated
Avoid alcohol
Report severe or persistent dizziness

Fatigue

Get adequate rest
Maintain regular sleep schedule
Exercise as tolerated
Report excessive tiredness that interferes with daily activities

Lifestyle Considerations

To maximize the benefits of Empagliflozin:

Follow a healthy, balanced diet
Exercise regularly as recommended by your doctor
Maintain a healthy weight
Avoid alcohol or limit consumption
Don't smoke
Manage stress through relaxation techniques
Get adequate sleep
Stay well hydrated
Keep all follow-up appointments
Take medication consistently as prescribed

When to Contact Your Doctor

Seek immediate medical attention if you experience:

Signs of severe allergic reaction (difficulty breathing, severe rash, swelling)
Chest pain or rapid heartbeat
Severe dizziness or fainting
Unusual bleeding or bruising
Signs of liver problems (yellowing of skin/eyes, dark urine, severe fatigue)
Severe stomach pain
Any symptoms that concern you

Contact your doctor for non-emergency issues:

Mild to moderate side effects that persist
Questions about your medication
Concerns about effectiveness
New medications prescribed by another doctor
Scheduled surgery or dental procedures
Planning pregnancy

Storage

Store Empagliflozin at room temperature (68-77°F or 20-25°C) away from light, heat, and moisture. Keep in original container. Keep out of reach of children and pets. Do not use past expiration date.

Important Reminders

Take exactly as prescribed by your doctor
Don't stop suddenly without medical advice
Keep all follow-up appointments
Report any unusual symptoms
Don't share medication with others
Store safely away from children
Check expiration dates
Ask your pharmacist if you have questions

Clinical Benefits

When used appropriately, Empagliflozin provides several benefits:

Effective management of type 2 diabetes and heart failure
Improvement in quality of life
Reduction in symptoms
Prevention of complications
Generally well-tolerated when used as directed
Backed by clinical research and extensive use

Disclaimer: This information is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your physician or other qualified healthcare provider with any questions about a medical condition or medication.

Frequently Asked Questions

Empagliflozin blocks reabsorption of glucose in the kidney, causing excess glucose to be excreted in the urine. Because it acts only when blood glucose is elevated above the renal threshold (typically around 180 mg/dL), it rarely causes hypoglycemia on its own. Hypoglycemia can occur, however, when empagliflozin is combined with insulin or sulfonylureas.

Increased urination is expected because empagliflozin works by causing the kidneys to excrete glucose along with extra water. Most patients adjust within 4 to 6 weeks. Drink fluids to stay hydrated, especially in the Florida heat. Contact your provider if you become lightheaded, dizzy, or notice dramatically reduced urine output despite drinking — these can signal volume depletion.

SGLT2 inhibitors can rarely cause "euglycemic" diabetic ketoacidosis — DKA with blood glucose levels that look near-normal. Warning symptoms include nausea, vomiting, abdominal pain, fatigue, and difficulty breathing. Hold empagliflozin and seek urgent evaluation if these symptoms develop, especially during illness, dehydration, fasting, surgery, or low-carbohydrate diets.

Large randomized trials (EMPEROR-Reduced and EMPEROR-Preserved) showed empagliflozin reduces heart failure hospitalizations and cardiovascular death in patients with both reduced and preserved ejection fraction, regardless of diabetes status. The mechanisms are still being defined but appear to include favorable effects on cardiac metabolism, renal hemodynamics, and reductions in preload and afterload.

Glucose in the urine creates a more favorable environment for yeast and some bacteria. Genital fungal infections (especially in women) and, less commonly, urinary tract infections can occur. Good genital hygiene, prompt urination after intercourse, and quick attention to early symptoms substantially reduce risk. A rare but serious complication called Fournier gangrene has been reported — seek emergency care for severe perineal pain, swelling, or redness with fever.

Yes — temporarily holding empagliflozin during major illness with poor oral intake, severe vomiting, or before scheduled surgery (typically 3 days before) reduces the risk of euglycemic DKA. Resume the medication once you are eating and drinking normally and your provider clears you to restart. Do not stop the medication without guidance for routine minor illnesses.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

✓Is empagliflozin appropriate for me given my kidney function and other medications?
✓How will my insulin or sulfonylurea dose be adjusted to prevent hypoglycemia?
✓What sick-day rules should I follow for holding empagliflozin during illness or surgery?
✓How often should we check my kidney function and electrolytes after starting?
✓Could empagliflozin help my heart or kidney health independent of my blood sugar?

Schedule an Appointment

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Attention Deficit Hyperactivity Disorder (ADHD)

ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and/or impulsivity, stemming from complex interactions between genetics, brain differences, and environmental factors, not poor parenting.

Learn More

Lupus Anticoagulant

Lupus anticoagulant is an antibody causing paradoxical prolonged clotting tests yet increasing thrombosis risk, linked to antiphospholipid syndrome and autoimmune diseases, despite not always requiring lupus diagnosis.

Learn More

Vertigo

Vertigo, a spinning sensation distinct from dizziness, often stems from inner ear or brain issues like BPPV or Meniere's, sometimes triggered by head trauma or medication.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.